OGN250516C20000
- 0.01
- 0.000.00%
Organon & Co Newsroom
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump's Drug Price Cuts: Will They Work?
Express News | Trump: Drug Prices to Be Cut by 59%, Plus Gasoline, Energy, Groceries, and All Other Costs, Down
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
CEO & Director of Organon Picks Up 14% More Stock
EU Regulator Finds Suicidal Thoughts as a Side Effect of Hair Loss Therapy
New Analyst Forecast: $OGN Given $10.0 Price Target
Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment
Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon
Organon & Co Insider Bought Shares Worth $299,370, According to a Recent SEC Filing
Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Cuts Target Price to $10
Organon Shares Are Trading Lower After Morgan Stanley Cut Its Price Target on the Stock From $15 to $10.
Organon & Is Maintained at Equal-Weight by Morgan Stanley
Express News | Morgan Stanley Maintains Equal-Weight on Organon, Lowers Price Target to $10
Organon Analyst Ratings
Research Alert: CFRA Retains Sell View On Shares Organon & Co.
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
Trending Stocks as U.S.market Posts Another Week of Rebound
Evercore Downgrades Organon & Co(OGN.US) to Hold Rating
Organon & Co | 10-Q: Q1 2025 Earnings Report